Clinical trial
Anti-plaque Effect of 0.12% Chlorhexidine Gluconate Rinsing and Nanoparticle Solution of 0.3% Melaleuca Alternifolia: A Randomized Crossover Clinical Trial
NCT02695901 is registered in ClinicalTrials.gov with Universidade Federal de Santa Maria as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Anti-plaque Effect of 0.12% Chlorhexidine Gluconate Rinsing and Nanoparticle Solution of 0.3% Melaleuca Alternifolia: A Randomized Crossover Clinical Trial
- Lead sponsor
- Universidade Federal de Santa Maria
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- March 31, 2016
- Completion date
- December 31, 2016
- Enrollment
- 59 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.